> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 7 Topics Discussed at MDUFA 5 Reauthorization Meeting
- URL: https://www.fdaweb.com/7-topics-discussed-at-mdufa-5-reauthorization-meeting/
- Published: 2021-04-28T12:00:00.000Z
- Updated: 2026-09-14T16:56:47.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5149210

The 3/17 FDA/industry MDUFA 5 reauthorization meeting covered these seven topics: FDA presentation of stakeholder feedback from various sources; FDA perspective on MDUFA 4 performance; MDUFA 4 financial information; FDA overview of digital transformation; fully-loaded full-time equivalent cost model methodology; industry perspective on reauthorization, and FDA overview on recruitment and retention.

A meeting [summary](https://www.fda.gov/media/147718/download?ref=fdaweb.com) issued by the agency includes details from each of the discussions.